Osprey Private Wealth’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
Osprey Private Wealth's ABBV Position: Q3 2026 in Review
Osprey Private Wealth increased its AbbVie (ABBV) stake by 2.2% in Q3 2026, buying an estimated $345K and bringing the position to 61,351 shares worth $16M. The position accounts for 3.88% of the portfolio, ranked #6.
Osprey Private Wealth first reported a position in ABBV in Q3 2024 and has held it in 9 quarters since. 4,192 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.
- Osprey Private Wealth held 61,351 shares of AbbVie worth $16M as of Q3 2026.
- Osprey Private Wealth bought 1,345 AbbVie shares in Q3 2026, an estimated $345K.
- AbbVie made up 3.88% of Osprey Private Wealth's portfolio in Q3 2026, its #6 holding.
- Osprey Private Wealth first reported a position in AbbVie in Q3 2024 and has held it in 9 quarters since.
- 4,192 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.
Based on Osprey Private Wealth's 13F filing for Q3 2026, filed 10 Nov 2026.